← Browse by Condition
Medical Condition

helicobacter pylori infections

Total Trials
2
Recruiting Now
2
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for helicobacter pylori infections sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 4
2
Top Sponsors
International Agency for Research on Cancer 1 trial
Nanjing First Hospital, Nanjing Medical University 1 trial
NCT02047994 Phase 4
Recruiting

Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality

Enrollment
30,000 pts
Location
Latvia
Sponsor
International Agency for Resea...
View Trial →
NCT07306988 Phase 4
Recruiting

Eradication of Helicobacter Pylori Improves Metabolic Syndrome Through Modulation of Gut Microbiota.

Enrollment
120 pts
Location
China
Sponsor
Nanjing First Hospital, Nanjin...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology